| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Magenta Therapeutics, Inc. | Chief Technical Officer | Stock Option (Right to Buy) | 75,000 | 01 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DNTH | Magenta Therapeutics, Inc. | 01 Aug 2022 | 1 | $0 | 4 | Chief Technical Officer | 01 Aug 2022, 21:13 |
| DNTH | Magenta Therapeutics, Inc. | 17 May 2022 | 1 | $0 | 4 | Chief Technical Officer | 19 May 2022, 16:20 |
| DNTH | Magenta Therapeutics, Inc. | 15 Feb 2022 | 1 | $0 | 4 | Chief Technical Officer | 17 Feb 2022, 16:18 |
| DNTH | Magenta Therapeutics, Inc. | 16 Sep 2021 | 1 | -$38,321 | 4 | Chief Technical Officer | 20 Sep 2021, 17:00 |
| DNTH | Magenta Therapeutics, Inc. | 14 Sep 2021 | 1 | $0 | 4 | Chief Technical Officer | 16 Sep 2021, 19:39 |
| DNTH | Magenta Therapeutics, Inc. | 19 Apr 2021 | 1 | $0 | 4/A | Chief Technical Officer | 17 May 2021, 17:07 |